Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cancer Cell|January 18, 2014
Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responsesXuanming Yang, Xunmin Zhang, May Lynne Fu, et al.Cancer Management and Research|September 15, 2021
A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer ImmunotherapyJie Liang, Huihui Zhang, Yue Huang, et al.Journal for Immunotherapy of Cancer|May 9, 2025
BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancerHuihui Zhang, Liliang Xia, Wendi Xuzhang, et al.Cancers|November 13, 2021
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSCLilv Fan, Guiliang Xu, Jingjing Cao, et al.Science Translational Medicine|January 28, 2021
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activityHuihui Zhang, Fanlin Li, Jiang Cao, et al.The Journal of Experimental Medicine|February 26, 2015
CD160 is essential for NK-mediated IFN-γ productionTony C Tu, Nicholas K Brown, Tae-Jin Kim, et al.Cancer Letters|January 18, 2024
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulationLing Chen, Guiying Xu, Xiaoxu Song, et al.Molecular Therapy. Methods & Clinical Development|May 19, 2021
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infectionXiaoqing Zhang, Ping Han, Haiyong Wang, et al.Science Translational Medicine|June 18, 2025
OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in miceHuihui Zhang, Runbo Zhong, Wanting Wang, et al.Cancer Cell|August 17, 2010
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunitySaeGwang Park, Zhujun Jiang, Eric D Mortenson, et al.Pageof 4